Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients

European Journal of Cancer

Volumn 49, Issue 1, 2013, Pages 98-105

  Bjerregaard, J K ^a,b   Mortensen, M B ^a   Schonnemann, K R ^a,b   Pfeiffer, P ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Accrual; Chemotherapy; Clinical trial; Generalisability; Pancreatic cancer; Patient characteristic; Survival

Indexed keywords

CAPECITABINE; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COHORT STUDIES; COMBINED MODALITY THERAPY; DENMARK; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 84871404118     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.07.017     Document Type: Article

References (28)

1. H. Sorbye, P. Pfeiffer, and N. Cavalli-Bjorkman Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients Cancer 115 20 2009 4679 4687
2. A.R. De, S. Francisci, and P. Baili The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis Eur J Cancer 45 6 2009 909 930
3. H. Oettle, S. Post, and P. Neuhaus Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 3 2007 267 277 (Pubitemid 46143304)
4. S.R. Bramhall, W.H. Allum, A.G. Jones, A. Allwood, C. Cummins, and J.P. Neoptolemos Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study Br J Surg 82 1 1995 111 115
5. L. Sharp, A.E. Carsin, D.P. Cronin-Fenton, D. O'Driscoll, and H. Comber Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland Eur J Cancer 45 8 2009 1450 1459
6. M. Hedberg, A. Borgstrom, S. Genell, and L. Janzon Survival following pancreatic carcinoma: a follow-up study of all cases recorded in Malmo, Sweden, 1977-1991 Br J Surg 85 12 1998 1641 1644 (Pubitemid 28548339)
7. S. Linder, L. Bostrom, and B. Nilsson Pancreatic carcinoma incidence and survival in Sweden in 1980-2000: a population-based study of 16,758 hospitalized patients with special reference to different therapies Eur J Surg Oncol 33 5 2007 616 622 (Pubitemid 46746530)
8. N.N. Baxter, B.A. Whitson, and T.M. Tuttle Trends in the treatment and outcome of pancreatic cancer in the United States Ann Surg Oncol 14 4 2007 1320 1326 (Pubitemid 46536816)
9. Y. Shaib, J. Davila, C. Naumann, and H. El-Serag The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study Am J Gastroenterol 102 7 2007 1377 1382 (Pubitemid 46976285)
10. T.S. Riall, W.H. Nealon, and J.S. Goodwin Pancreatic cancer in the general population: Improvements in survival over the last decade J Gastrointest Surg 10 9 2006 1212 1223
11. M.A. Eloubeidi, R.A. Desmond, and C.M. Wilcox Prognostic factors for survival in pancreatic cancer: a population-based study Am J Surg 192 3 2006 322 329 (Pubitemid 44226455)
12. F.J. van Oost, E.J. Luiten, L.V. van de Poll-Franse, J.W. Coebergh, and A.J. Van den Eijnden-van Raaij Outcome of surgical treatment of pancreatic, peri-ampullary and ampullary cancer diagnosed in the south of The Netherlands: a cancer registry based study Eur J Surg Oncol 32 5 2006 548 552
13. K.Y. Bilimoria, D.J. Bentrem, and C.Y. Ko Multimodality therapy for pancreatic cancer in the U.S.: utilization, outcomes, and the effect of hospital volume Cancer 110 6 2007 1227 1234 (Pubitemid 47435592)
14. M.K. Krzyzanowska, C.C. Earle, K.M. Kuntz, and J.C. Weeks Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 67 1 2007 211 218 (Pubitemid 44959514)
15. H.H. Storm, E.V. Michelsen, I.H. Clemmensen, and J. Pihl The Danish Cancer Registry-history, content, quality and use Dan Med Bull 44 5 1997 535 539
16. K. Hirao, H. Kawamoto, and I. Sakakihara A 4-week versus a 3-week schedule of gemcitabine monotherapy for advanced pancreatic cancer: a randomized phase II study to evaluate toxicity and dose intensity Int J Clin Oncol 16 6 2011 637 645
17. D. Ansari, A. Rosendahl, J. Elebro, and R. Andersson Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer Br J Surg 98 8 2011 1041 1055
18. N.B. Jamieson, C.R. Carter, C.J. McKay, and K.A. Oien Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis Clin Cancer Res 17 10 2011 3316 3331
19. F. Huguet, T. Andre, and P. Hammel Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies J Clin Oncol 25 3 2007 326 331 (Pubitemid 350003022)
20. J.K. Bjerregaard, M.B. Mortensen, H.A. Jensen, M. Nielsen, and P. Pfeiffer Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy Int J Radiat Oncol Biol Phys 83 3 2012 909 915
21. D. Cunningham, I. Chau, and D.D. Stocken Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer J Clin Oncol 27 33 2009 5513 5518
22. T. Conroy, F. Desseigne, and M. Ychou FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N Engl J Med 364 19 2011 1817 1825
23. R.D. Cress, D. Yin, L. Clarke, R. Bold, and E.A. Holly Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States) Cancer Causes Control 17 4 2006 403 409
24. C.J. Wakeman, I.G. Martin, R.W. Robertson, B.R. Dobbs, and F.A. Frizelle Pancreatic cancer: management and survival ANZ J Surg 74 11 2004 941 944
25. M. David, C. Lepage, and J.L. Jouve Management and prognosis of pancreatic cancer over a 30-year period Br J Cancer 101 2 2009 215 218
26. I.K. Larsen, M. Smastuen, and T.B. Johannesen Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness Eur J Cancer 45 7 2009 1218 1231
27. L.S. Elting, C. Cooksley, and B.N. Bekele Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants Cancer 106 11 2006 2452 2458 (Pubitemid 43787670)
28. B.F. El-Rayes, P. Jasti, and R.K. Severson Impact of race, age, and socioeconomic status on participation in pancreatic cancer clinical trials Pancreas 39 7 2010 967 971